Preventive TB Therapy during Pregnancy Causes Excessive Adverse Events
Date: 03/08/2018
Publication:
Healio Infectious Disease
Researchers reported that the immediate initiation of isoniazid preventive therapy for tuberculosis during pregnancy produced an unexpectedly high incidence rate of severe treatment-related adverse events among women with HIV. However, they said the rate was comparable to that among women who initiated therapy postpartum, suggesting that women should be given a choice of when to initiate therapy.